Skip to Content

Acetaminophen / butalbital / caffeine Pregnancy and Breastfeeding Warnings

Acetaminophen / butalbital / caffeine is also known as: Alagesic, Alagesic LQ, Anolor 300, Anoquan, Arcet, Capacet, Dolmar, Esgic, Esgic-Plus, Femcet, Fioricet, Fiorpap, G-1, Geone, Isocet, Margesic, Pacaps, Pharmagesic, Repan, Tenake, Tencet, Triad, Two-Dyne, Vanatol LQ, Zebutal

Acetaminophen / butalbital / caffeine Pregnancy Warnings

Use is not recommended unless clearly needed US FDA pregnancy category: C Comment: Monitor for barbiturate withdrawal in neonates

Animal reproduction studies have not been conducted on this combination product. Epidemiologic data for acetaminophen, including a population based case-control study from the National Birth Defects Prevention Study (n= 11,610) and data from 26,424 live singleton births have shown no increased risk of major birth defects in children with first trimester prenatal exposure. In 2015, the US Food and Drug Administration released results of their evaluation on published research studies looking at mothers who took acetaminophen (either over the counter or as a prescription product) at any time during their pregnancy and the risk of attention deficit hyperactivity (ADHD) in their babies. They found all studies reviewed had potential limitations in their designs that prevented drawing reliable conclusions. Barbiturates have been reported to readily cross the placental barrier. A 2-day old infant whose mother had taken a butalbital-containing product during the last two months of pregnancy experienced withdrawal seizures; butalbital was found in the infant's serum. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Acetaminophen / butalbital / caffeine Breastfeeding Warnings

Acetaminophen, butalbital, and caffeine are excreted into human milk in small concentrations. The significance of the effects on nursing infants has not been reported, but due to the potential for serious adverse reactions in nursing infants, other agents may be preferred.

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Yes (acetaminophen); Yes (barbiturates); Yes (caffeine)

See references

References for pregnancy information

  1. "Product Information. Esgic (acetaminophen/butalbital/caffeine)." Forest Pharmaceuticals, St. Louis, MO.
  2. U.S. Food and Drug Administration U.S. Food and Drug Administration U.S. Food and Drug Administration U.S. Food and Drug Administration "FDA Drug Safety Communication: FDA has reviewed possible risks of pain medicine use during pregnancy Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm429117.htm." (01/09/2015):
  3. "Product Information. Fioricet (APAP/butalbital/caffeine)." Novartis Pharmaceuticals, East Hanover, NJ.
  4. "Product Information. Vanatol LQ (acetaminophen/butalbital/caffeine)." GM Pharmaceuticals, Arlington, TX.
  5. "Product Information. Acetaminophen/Butalbital/Caffeine (acetaminophen/butalbital/caffeine)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc), Huntsville, AL.

References for breastfeeding information

  1. "Product Information. Fioricet (APAP/butalbital/caffeine)." Novartis Pharmaceuticals, East Hanover, NJ.
  2. "Product Information. Vanatol LQ (acetaminophen/butalbital/caffeine)." GM Pharmaceuticals, Arlington, TX.
  3. "Product Information. Acetaminophen/Butalbital/Caffeine (acetaminophen/butalbital/caffeine)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc), Huntsville, AL.
  4. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  5. "Product Information. Esgic (acetaminophen/butalbital/caffeine)." Forest Pharmaceuticals, St. Louis, MO.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide